Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases.

MLA

Morichika, Kazuho, et al. “Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T Cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases.” Internal Medicine (Tokyo, Japan), vol. 55, no. 10, 2016, pp. 1345–49. EBSCOhost, https://doi.org/10.2169/internalmedicine.55.5997.

APA

Morichika, K., Tomoyose, T., Hanashiro, T., Shimabukuro, N., Tamaki, K., Tedokon, I., Nishi, Y., Nakachi, S., Karube, K.-N., Fukushima, T., Katoh, T., Ohshima, K., & Masuzaki, H. (2016). Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases. Internal Medicine (Tokyo, Japan), 55(10), 1345–1349. https://doi.org/10.2169/internalmedicine.55.5997

Chicago

Morichika, Kazuho, Takeaki Tomoyose, Taeko Hanashiro, Natsuki Shimabukuro, Keita Tamaki, Iori Tedokon, Yukiko Nishi, et al. 2016. “Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T Cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases.” Internal Medicine (Tokyo, Japan) 55 (10): 1345–49. doi:10.2169/internalmedicine.55.5997.